NCT02510014: A reported trial by Indivior Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT02510014 |
|---|---|
| Title | An Open-Label, Long-Term Safety and Tolerability Study of Depot Buprenorphine (RBP-6000) in Treatment-Seeking Subjects With Opioid Use Disorder |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | July 27, 2015 |
| Completion date | Jan. 31, 2017 |
| Required reporting date | Jan. 31, 2020, midnight |
| Actual reporting date | Jan. 31, 2018 |
| Date last checked at ClinicalTrials.gov | March 26, 2026 |
| Days late | None |